CN109475522A - 改善癌症治疗 - Google Patents

改善癌症治疗 Download PDF

Info

Publication number
CN109475522A
CN109475522A CN201680086470.1A CN201680086470A CN109475522A CN 109475522 A CN109475522 A CN 109475522A CN 201680086470 A CN201680086470 A CN 201680086470A CN 109475522 A CN109475522 A CN 109475522A
Authority
CN
China
Prior art keywords
cor
composition
suppository
cancer
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680086470.1A
Other languages
English (en)
Chinese (zh)
Inventor
G·凯利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nex Pharmaceutical Co Ltd
Original Assignee
Nex Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nex Pharmaceutical Co Ltd filed Critical Nex Pharmaceutical Co Ltd
Publication of CN109475522A publication Critical patent/CN109475522A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201680086470.1A 2016-04-06 2016-07-28 改善癌症治疗 Pending CN109475522A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662318946P 2016-04-06 2016-04-06
US62/318,946 2016-04-06
PCT/AU2016/050674 WO2017173474A1 (en) 2016-04-06 2016-07-28 Improvements in cancer treatment

Publications (1)

Publication Number Publication Date
CN109475522A true CN109475522A (zh) 2019-03-15

Family

ID=60000141

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680086470.1A Pending CN109475522A (zh) 2016-04-06 2016-07-28 改善癌症治疗

Country Status (11)

Country Link
US (2) US20190160004A1 (enExample)
EP (2) EP3939583A1 (enExample)
JP (1) JP2019510830A (enExample)
KR (1) KR20190016017A (enExample)
CN (1) CN109475522A (enExample)
AU (2) AU2016401508B2 (enExample)
CA (1) CA3058479A1 (enExample)
IL (1) IL262143A (enExample)
RU (1) RU2018137897A (enExample)
SG (1) SG11201808777UA (enExample)
WO (1) WO2017173474A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019513826A (ja) * 2016-04-06 2019-05-30 ノクソファーム リミティド 放射線療法の改善
CA3058503A1 (en) 2016-04-06 2017-10-12 Noxopharm Limited Isoflavonoid composition with improved pharmacokinetics
JP2023519990A (ja) 2020-03-30 2023-05-15 ノクソファーム リミティド 感染に関連する炎症の治療のための方法
WO2022204757A1 (en) * 2021-03-30 2022-10-06 Noxopharm Limited Improved isoflavone formulation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008503A1 (en) * 1996-08-30 1998-03-05 Novogen Research Pty. Ltd. Therapeutic methods and compositions involving isoflavones
CN102215841A (zh) * 2008-08-29 2011-10-12 诺沃根研究控股有限公司 免疫调节活性

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8178123B2 (en) * 2001-08-29 2012-05-15 Femina Pharma Incorporated Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
CN1681386B (zh) * 2002-07-24 2010-05-26 儿童医院医疗中心 含有对映体牛尿酚的组合物和产物及其制备方法
AU2002951833A0 (en) * 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
JP2007525485A (ja) 2003-11-19 2007-09-06 ノボゲン リサーチ ピーティーワイ リミテッド 複合的な放射線治療及び化学治療の組成物及び方法
DE102005009515A1 (de) * 2005-02-25 2006-09-07 Exner, Heinrich, Dr. Verfahren zur Herstellung einer Zubereitung einer DMSO-haltigen festen Silikonölemulsion zur Bindung von reaktiven Sauerstoffverbindungen im Körper von Menschen und Tieren
EP1948103A2 (en) * 2005-09-15 2008-07-30 UMD, Inc. A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration
US20110166142A1 (en) * 2007-06-29 2011-07-07 Eleanor Eiffe 2-substituted isoflavonoid compounds, medicaments and uses
KR20110004525A (ko) * 2009-07-08 2011-01-14 동의대학교 산학협력단 제니스테인과 ｔｒａｉｌ을 포함하는 간암 치료용 조성물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008503A1 (en) * 1996-08-30 1998-03-05 Novogen Research Pty. Ltd. Therapeutic methods and compositions involving isoflavones
CN102215841A (zh) * 2008-08-29 2011-10-12 诺沃根研究控股有限公司 免疫调节活性

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LIPP M等: "Review of cocoa butter and alternative fats for use in chocolate-Part A. Compositional data", 《FOOD CHEMISTRY》 *
李威等: "《药剂学》", 28 February 2014, 湖北科学技术出版社 *

Also Published As

Publication number Publication date
RU2018137897A3 (enExample) 2020-05-13
EP3439651A4 (en) 2019-10-30
IL262143A (en) 2018-11-29
SG11201808777UA (en) 2018-11-29
AU2020204172A1 (en) 2020-07-09
RU2018137897A (ru) 2020-05-13
WO2017173474A1 (en) 2017-10-12
EP3939583A1 (en) 2022-01-19
KR20190016017A (ko) 2019-02-15
AU2016401508A1 (en) 2018-11-01
AU2016401508B2 (en) 2020-03-26
JP2019510830A (ja) 2019-04-18
EP3439651A1 (en) 2019-02-13
CA3058479A1 (en) 2017-10-12
US20190160004A1 (en) 2019-05-30
US20210338576A1 (en) 2021-11-04

Similar Documents

Publication Publication Date Title
US20210338576A1 (en) Cancer treatment
Zhong et al. Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin
WO2007056941A1 (fr) Utilisation de composes a base d'isothiocyanates dans le traitement de maladies prostatiques et du cancer de la peau
AU2021266308B2 (en) Chemotherapy improvements
AU2017247008B2 (en) Isoflavonoid composition with improved pharmacokinetics
Liu et al. Leonurine: a comprehensive review of pharmacokinetics, pharmacodynamics, and toxicology
Guo et al. Research Progress on Quercetin's Biological Activity and Structural Modification Based on Its Antitumor Effects
HK40006250A (en) Improvements in cancer treatment
JP7105465B2 (ja) キニーネ塩懸濁液を含む抗癌治療のための局所投与用注射剤組成物及び懸濁液注射剤の製造方法
Man et al. Autophagy and green tea epigallocatechin-3-gallate: Applications to female reproductive cancers
WO2017173497A1 (en) Targeted drug delivery
WO2015021922A1 (zh) 人参皂苷Rd或其肠溶制剂及用途
HK1138797A (zh) 肝癌治疗剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40006250

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190315